Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Hemant Surgical Industries Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Hemant Surgical Industries Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Hemant Surgical Ind. has submitted to BSE the Shareholding Pattern for the Period Ended May 15, 2026

    19 May 2026, 3:10PM As of May 2026, 52.83% is owned by Indian Promoters and 47.17% by Public. <p align=justify> Top five Promoters holding highest number of shares of Hem
  • Hemant Surgical Ind. - Announcement under Regulation 30 (LODR)-Allotment

    15 May 2026, 6:06PM Allotment of 14,99,200 Equity Shares consequent to conversion of Convertible Warrants
  • Hemant Surgical Ind. - Intimation Of Appointment Of Cost Auditor

    15 May 2026, 5:36PM The Board of Directors at its meeting held today has appointment M/s. K Sorathiya & Co, Practicing Cost Accountants as Cost Auditor of the Company for
  • Hemant Surgical Ind. - Intimation Of Appointment Of Internal Auditor

    15 May 2026, 5:28PM The Board of Directors at its Meeting held today has appointed M/s. A D M S and Company, Chartered Accountant as Internal Auditor of the Company for F
  • Hemant Surgical Ind. - Intimation Of Appointment Of Secretarial Auditor

    15 May 2026, 5:26PM The Board of Directors at its Meeting held today has appointed M/s. NKM & Associates as Secretarial Auditor of the Company for F.Y. 26-27
  • Hemant Surgical Ind. - Audited Financial Results Of The Company For Half And Financial Year Ended March 31, 2026

    15 May 2026, 5:13PM Audited Financial Results of the Company for half and financial year ended March 31, 2026
  • Hemant Surgical Ind. - Board Meeting Outcome for Outcome Of The Board Meeting Pursuant To Regulation 30 And 33 Of SEBI (Listi

    15 May 2026, 4:52PM The Board of Directors at its meeting held today have approved Audited Financial Results of the Company for half and financial year ended March 31, 20
  • Hemant Surgical Ind. - Board Meeting Intimation for Audited Standalone And Consolidated Financial Results Of The Company For

    9 May 2026, 9:35PM Hemant Surgical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 ,inter alia, to co
  • Hemant Surgical Ind. has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    17 Apr 2026, 4:40PM As of March 2026, 58.90% is owned by Indian Promoters and 41.10% by Public. <p align=justify> Top five Promoters holding highest number of shares of H
  • Hemant Surgical Ind. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Apr 2026, 12:13PM Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2026.
  • Hemant Surgical Ind. - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

    2 Apr 2026, 12:42PM The Company has executed C-ARM Development and Supply Agreement with GBT Korea Co, Ltd, Republic of Korea.
  • Hemant Surgical Ind. - Execution Of Semi Knocked Down (SKD) Manufacturing Agreement With Sonomed Escalon, USA

    31 Mar 2026, 11:00PM The Company has entered into Strategic Semi Knocked Down (SKD) Manufacturing Agreement with Sonomed Escalon, USA

Key fundamentals

Evaluate the intrinsic value of Hemant Surgical Industries Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 187.1685 93.8336 61.6113 30.7183 22.8857
Liabilities 187.1685 93.8336 61.6113 30.7183 22.8857
Equity 13.0384 10.44 10.44 7.68 2
Gross Profit 23.3897 9.0721 10.4706 10.4711 6.2994
Net Profit 18.2334 8.1321 9.7999 7.6511 4.614
Cash From Operating Activities -32.0227 8.9206 -7.558 8.6407 12.0638
NPM(%) 7.89 7.63 9.27 7 4.45
Revenue 230.9871 106.5266 105.6075 109.1482 103.57
Expenses 207.5974 97.4545 95.1369 98.6771 97.2706
ROE(%) 16.16 7.2 8.68 6.78 4.09

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Hemant Surgical Industries Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 728.00 3.57 0.00 241.24 -26.19 0.69
Lotus Eye Hospital and Institute Ltd 107.05 1.28 351.77 879.06 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 17.39 -0.80 0.00 1825.22 -39.50 0.00
Astec Lifesciences Ltd 751.15 -2.78 0.00 828.97 -363.15 0.00

Company Info

Our Company was originally incorporated as "Hemant Surgical Industries Private Limited" under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated March 27, 1989, bearing registration No.051133 issued by Registrar of Companies, Maharashtra, Mumbai and CIN No. U33110MH1989PTC051133. Subsequently our Company was converted into a public limited company vide special resolution passed by the shareholders at the Extra Ordinary General Meeting held on January 24, 1994 and the name of our Company was changed from "Hemant Surgical Industries Private Limited" to "Hemant Surgical Industries Limited" vide fresh Certificate of Incorporation granted to our Company consequent upon conversion into public limited company dated February 22, 1994 by the Registrar of Companies, Maharashtra, Mumbai bearing Corporate Identification Number U33110MH1989PLC051133.Major events and milestones:1989Incorporation of the Company in the name of "Hemant Surgical Private Limted"1993Became the Sole Agent for JMS Co. Ltd, Japan, for JMS, Meditape1994Conversion into Public Limited company with the name Hemant Surgical Industries Ltd.1999Started its first manufacturing plant at Achhad, Maharashtra for External Preparation and Small Volume Parentals2018Entered into exclusive distribution agreement dated July 01, 2018, valid for a period of 6 years, with JMS Co. Ltd., Japan for importing and marketing JMS Meditape in India. The imported meditape undergoes the process of rewinding, slitting, and packaging in our assembly unit situated at Atgaon and is then sold in Indian market.2019-Entered into technical collaboration agreement with JMS Singapore Pte. Ltd. for manufacturing Intravenous Infusion Set which are sold under the brand name "JMS" in India.-Signed exclusive distribution agreement with Hemant Phillipines Inc./ Mediply Inc. for supply of renal care equipment, medical devices and consumables for marketing the same in entire Phillipines.2021-Appointed as sole agent of SWS Hemodialysis Care Co. Ltd., Chinato sell and do maintenance of SWS4000A hemodialysis machines in West India on exclusive basis.-Entered into MOU with Dr. Venkatesh for setting up of dialysis centre at Guru Harikrishan Hospital 24*7 Dialysis Centre, New Delhi2022Achieved a Bench mark of 100 Cr Turnover in the FY 2021-22 2023 -Hemant Surgical Industries Limited (HSIL) made its Listing on the Bombay Stock Exchange-SME Platform and experienced a remarkable 100% surge in share price.

Our Company was originally incorporated as "Hemant Surgical Industries Private Limited" under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated March 27, 1989, bearing registration No.051133 issued by Registrar of Companies, Maharashtra, Mumbai and CIN No. U33110MH1989PTC051133. Subsequently our Company was converted into a public limited company vide special resolution passed by the shareholders at the Extra Ordinary General Meeting held on January 24, 1994 and the name of our Company was changed from "Hemant Surgical Industries Private Limited" to "Hemant Surgical Industries Limited" vide fresh Certificate of Incorporation granted to our Company consequent upon conversion into public limited company dated February 22, 1994 by the Registrar of Companies, Maharashtra, Mumbai bearing Corporate Identification Number U33110MH1989PLC051133.Major events and milestones:1989Incorporation of the Company in the name of "Hemant Surgical Private Limted"1993Became the Sole Agent for JMS Co. Ltd, Japan, for JMS, Meditape1994Conversion into Public Limited company with the name Hemant Surgical Industries Ltd.1999Started its first manufacturing plant at Achhad, Maharashtra for External Preparation and Small Volume Parentals2018Entered into exclusive distribution agreement dated July 01, 2018, valid for a period of 6 years, with JMS Co. Ltd., Japan for importing and marketing JMS Meditape in India. The imported meditape undergoes the process of rewinding, slitting, and packaging in our assembly unit situated at Atgaon and is then sold in Indian market.2019-Entered into technical collaboration agreement with JMS Singapore Pte. Ltd. for manufacturing Intravenous Infusion Set which are sold under the brand name "JMS" in India.-Signed exclusive distribution agreement with Hemant Phillipines Inc./ Mediply Inc. for supply of renal care equipment, medical devices and consumables for marketing the same in entire Phillipines.2021-Appointed as sole agent of SWS Hemodialysis Care Co. Ltd., Chinato sell and do maintenance of SWS4000A hemodialysis machines in West India on exclusive basis.-Entered into MOU with Dr. Venkatesh for setting up of dialysis centre at Guru Harikrishan Hospital 24*7 Dialysis Centre, New Delhi2022Achieved a Bench mark of 100 Cr Turnover in the FY 2021-22 2023 -Hemant Surgical Industries Limited (HSIL) made its Listing on the Bombay Stock Exchange-SME Platform and experienced a remarkable 100% surge in share price.

Read More

Parent Organisation

Hemant Surgical Industries Ltd.

Founded

27/03/1989

Managing Director

Mr.Hanskumar Shah

NSE Symbol

FAQ

The current price of Hemant Surgical Industries Ltd is

The 52-week high for Hemant Surgical Industries Ltd is

The market capitalization of Hemant Surgical Industries Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Hemant Surgical Industries Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Hemant Surgical Industries Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Hemant Surgical Industries Ltd shares.

The CEO of Hemant Surgical Industries Ltd is Mr.Hanskumar Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT